FindTrial
Sign In

Study for Safety and Efficiency of Therapeutic Angiogenesis for Patients With Limb Ischemia by Transplantation of Human Cord Blood Mononuclear Cell

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00518934
Enrollment
Unknown
Registered
2007-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2007-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemia

Keywords

Safety and efficiency of angiogenesis for patients with limb, ischemia by transplantation of human cord blood mononuclear, cells

Brief summary

The purpose of this study is to analyze the safety and efficiency of therapeutic angiogenesis for patients with limb ischemia by transplantation of human cord blood mononuclear cells.

Interventions

OTHERStudy for safety and efficiency of therapeutic angiogenesis for patients with limb ischemia by transplantation of human cord blood mononuclear cell

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 60 Years

Inclusion criteria

Patients with ischemic symptoms such as claudication, rest pain or nonhealing ischemic wound * Without evidence of improvement in response to conventional medical therapy * Not candidates for surgical intervention or radiologic intervention

Exclusion criteria

* Malignant disease * More than 60 years old * Other significant medical conditions, including diabetes mellitus, hypertension, hyperlipidemia, etc.

Countries

South Korea

Contacts

Primary ContactDong-Ik Kim, Professor
dikim@skku.edu82-2-3410-3467

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026